Tested Applications
| Positive WB detected in | SH-SY5Y cells, mouse skeletal muscle tissue, rat skeletal muscle tissue |
| Positive IHC detected in | human colon cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:300-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
13293-1-AP targets MS4A12 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag3968 Product name: Recombinant human MS4A12 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-100 aa of BC029793 Sequence: MMSSKPTSHAEVNETIPNPYPPSSFMAPGFQQPLGSINLENQAQGAQRAQPYGITSPGIFASSQPGQGNIQMINPSVGTAVMNFKEEAKALGVIQIMVGL Predict reactive species |
| Full Name | membrane-spanning 4-domains, subfamily A, member 12 |
| Calculated Molecular Weight | 267 aa, 28 kDa |
| Observed Molecular Weight | 35 kDa |
| GenBank Accession Number | BC029793 |
| Gene Symbol | MS4A12 |
| Gene ID (NCBI) | 54860 |
| RRID | AB_10596915 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9NXJ0 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for MS4A12 antibody 13293-1-AP | Download protocol |
| WB protocol for MS4A12 antibody 13293-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The anti-MS4A12 antibody (catalog #13293-1-AP) has 1 total citation. It appears in Radiation Oncology (2025), where researchers investigated elevated MS4A12 expression as an indicator of resistance to concurrent chemoradiotherapy and its association with inferior survival in rectal cancer patients. The study applied the antibody via IHC in human tissue samples, placing it within the research fields of oncology and radiation therapy resistance.
| Species | Application | Title |
|---|---|---|
Radiat Oncol Elevated MS4A12 expression is indicative of resistance to concurrent chemoradiotherapy and inferior survival in patients with rectal cancer. |







